Immune Thrombocytopenia and Pregnancy Questions & Answers

1. Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets. 2019 Jul 11. 1-7. [Medline].

2. Care A, Pavord S, Knight M, Alfirevic Z. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG. 2018 Apr. 125 (5):604-612. [Medline].

3. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003 Dec 15. 102 (13):4306-11. [Medline].

4. Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017 Jun. 16 (6):620-632. [Medline].

5. Wyszynski DF, Carman WJ, Cantor AB, Graham JM Jr, Kunz LH, Slavotinek AM, et al. Pregnancy and Birth Outcomes among Women with Idiopathic Thrombocytopenic Purpura. J Pregnancy. 2016. 2016:8297407. [Medline]. [Full Text].

6. Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017 Nov 23. 130 (21):2271-2277. [Medline]. [Full Text].

7. Sainio S, Jarvenpaa AL, Renlund M. Thrombocytopenia in term infants: a population-based study. Obstet Gynecol. 2000 Mar. 95(3):441-6. [Medline].

8. Blanchette VS, Chen L, de Friedberg ZS. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol. 1990 Feb. 74(2):209-15. [Medline].

9. Dreyfus M, Kaplan C, Verdy E. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood. 1997 Jun 15. 89(12):4402-6. [Medline].

10. Davis GL. Platelet specific alloantigens. Clin Lab Sci. 1998 Nov-Dec. 11(6):356-61. [Medline].

11. Bussel JB. Immune thrombocytopenia in pregnancy: autoimmune and alloimmune. J Reprod Immunol. 1997 Dec 15. 37(1):35-61. [Medline].

12. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 166: Thrombocytopenia in Pregnancy. Obstet Gynecol. 2016 Sep. 128 (3):e43-53. [Medline].

13. Durand-Zaleski I, Schlegel N, Blum-Boisgard C. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol. 1996 Oct. 13(7):423-31. [Medline].

14. George JN, el-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov 3. 331(18):1207-11. [Medline].

15. Herman JH, Jumbelic MI, Ancona RJ. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Pediatr Hematol Oncol. 1986 Winter. 8(4):312-7. [Medline].

16. Monteith C, Ní Áinle F, Cooley S, Lambert JS, Kelleher B, Jackson V, et al. Hepatitis C virus-associated thrombocytopenia in pregnancy: impact upon multidisciplinary care provision. J Perinat Med. 2014 Jan. 42(1):135-8. [Medline].

17. Yamada H, Kato EH, Kobashi G. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Semin Thromb Hemost. 1999. 25(5):491-6. [Medline].

18. Biswas A, Arulkumaran S, Ratnam SS. Disorders of platelets in pregnancy. Obstet Gynecol Surv. 1994 Aug. 49(8):585-94. [Medline].

19. Kadir RA, McLintock C. Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost. 2011 Sep. 37(6):640-52. [Medline].

20. Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol. 2012 Jan. 87(1):15-21. [Medline].

21. Christiaens GC, Nieuwenhuis HK, von dem Borne AE. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol. 1990 Oct. 97(10):893-8. [Medline].

22. Gresikova M. Learning from errors: when a low platelet count in neonate excludes immune thrombocytopenic purpura in mother. Bratisl Lek Listy. 2013. 114(4):232-6. [Medline].

23. Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013 Jan 3. 121(1):38-47. [Medline].

24. Cohen DL, Baglin TP. Assessment and management of immune thrombocytopenia in pregnancy and in neonates. Arch Dis Child Fetal Neonatal Ed. 1995 Jan. 72(1):F71-6. [Medline].

25. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002 Mar 28. 346(13):995-1008. [Medline].

26. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003 Dec 15. 102 (13):4306-11. [Medline].

27. Gernsheimer TB. Thrombocytopenia in pregnancy: is this immune thrombocytopenia or...?. Hematology Am Soc Hematol Educ Program. 2012. 2012:198-202. [Medline].

28. Martí-Carvajal AJ, Peña-Martí GE, Comunián-Carrasco G. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. Cochrane Database Syst Rev. 2009 Oct 7. CD007722. [Medline].

29. Sukenik-Halevy R, Ellis MH, Fejgin MD. Management of immune thrombocytopenic purpura in pregnancy. Obstet Gynecol Surv. 2008 Mar. 63(3):182-8. [Medline].

30. Gasim T. Immune thrombocytopenic purpura in pregnancy: a reappraisal of obstetric management and outcome. J Reprod Med. 2011 Mar-Apr. 56(3-4):163-8. [Medline].

31. Mithoowani S, Gregory-Miller K, Goy J, Miller MC, Wang G, Noroozi N, et al. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2016 Oct. 3 (10):e489-e496. [Medline].

32. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000 Dec. 62(6):385-92. [Medline].

33. Howman RA, Barr AL, Shand AW, Dickinson JE. Antenatal intravenous immunoglobulin in chronic immune thrombocytopenic purpura: case report and literature review. Fetal Diagn Ther. 2009. 25(1):93-7. [Medline].

34. van der Lugt NM, van Kampen A, Walther FJ, Brand A, Lopriore E. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. Vox Sang. 2013 Oct. 105(3):236-43. [Medline].

35. Bussel JB, Graziano JN, Kimberly RP. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood. 1991 May 1. 77(9):1884-93. [Medline].

36. Scaradavou A, Woo B, Woloski BM. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997 Apr 15. 89(8):2689-700. [Medline].

37. Nicolescu A, Vladareanu AM, Voican I, Onisai M, Vladareanu R. Therapeutic Options for Immune Thrombocytopenia (ITP) During Pregnancy. Maedica (Buchar). 2013 Jun. 8(2):182-188. [Medline].

38. Copel JA, Gollin YG, Grannum PA. Alloimmune disorders and pregnancy. Semin Perinatol. 1991 Jun. 15(3):251-6. [Medline].

39. Khan AM, Mydra H, Nevarez A. Clinical Practice Updates in the Management Of Immune Thrombocytopenia. P T. 2017 Dec. 42 (12):756-763. [Medline].

40. Bussel JB, Zabusky MR, Berkowitz RL. Fetal alloimmune thrombocytopenia. N Engl J Med. 1997 Jul 3. 337(1):22-6. [Medline].

41. Patil AS, Dotters-Katz SK, Metjian AD, James AH, Swamy GK. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Obstet Gynecol. 2013 Aug. 122(2 Pt 2):483-5. [Medline]. [Full Text].

42. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011 Feb 3. 117(5):1499-506. [Medline].

43. Kaplan C, Daffos F, Forestier F. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood. 1988 Jul. 72(1):340-3. [Medline].

44. Nicolini U, Tannirandorn Y, Gonzalez P. Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia. Am J Obstet Gynecol. 1990 Oct. 163(4 Pt 1):1144-6. [Medline].

45. Murphy MF, Pullon HW, Metcalfe P. Management of fetal alloimmune thrombocytopenia by weekly in utero platelet transfusions. Vox Sang. 1990. 58(1):45-9. [Medline].

46. Lynch L, Bussel JB, McFarland JG. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol. 1992 Jul. 80(1):67-71. [Medline].

47. Bussel JB, Berkowitz RL, Lynch L. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol. 1996 May. 174(5):1414-23. [Medline].

48. Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol. 2001. 185(3):683-8.

49. Winkelhorst D, Murphy MF, Greinacher A, Shehata N, Bakchoul T, Massey E, et al. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 2017 Mar 16. 129 (11):1538-1547. [Medline]. [Full Text].

50. Giers G, Wenzel F, Fischer J, et al. Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia. Vox Sang. 2009 Oct 27. [Medline].

51. Stavrou E, McCrae KR. Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am. 2009 Dec. 23 (6):1299-316. [Medline].

52. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26. 3 (22):3780-3817. [Medline]. [Full Text].

53. [Guideline] British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003 Feb. 120 (4):574-96. [Medline]. [Full Text].

54. Kawaguchi K, Matsubara K, Takafuta T, Shinzato I, Tanaka Y, Iwata A, et al. Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol. 2014 May. 99(5):570-6. [Medline].

55. Yamada H, Kato EH, Kishida T. Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura. Ann Hematol. 1998 May. 76(5):211-4. [Medline].

56. Mahey R, Kaur SD, Chumber S, Kriplani A, Bhatla N. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura. BMJ Case Rep. 2013 Dec 20. 2013:[Medline].

57. Moise KJ Jr, Patton DE, Cano LE. Misdiagnosis of a normal fetal platelet count after coagulation of intrapartum scalp samples in autoimmune thrombocytopenic purpura. Am J Perinatol. 1991 Sep. 8(5):295-6. [Medline].

58. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv. 1993 Dec. 48(12):781-8. [Medline].

59. Berry SM, Leonardi MR, Wolfe HM. Maternal thrombocytopenia. Predicting neonatal thrombocytopenia with cordocentesis. J Reprod Med. 1997 May. 42(5):276-80. [Medline].

60. Cook RL, Miller RC, Katz VL. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol. 1991 Oct. 78(4):578-83. [Medline].

61. Bussel J, Kaplan C. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. Baillieres Clin Haematol. 1998 Jun. 11(2):391-408. [Medline].

62. Kawaguchi K, Matsubara K, Takafuta T, Shinzato I, Tanaka Y, Iwata A, et al. Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol. 2014 Mar 13. [Medline].

63. Mahey R, Kaur SD, Chumber S, Kriplani A, Bhatla N. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura. BMJ Case Rep. 2013 Dec 20. 2013:[Medline].

64. [Guideline] Rajasekhar A, Gernsheimer T, Stasi R, James AH. 2013 Clinical Practice Guide on Thrombocytopenia in Pregnancy. American Society of Hematology. Available at http://www.hematology.org/Clinicians/Guidelines-Quality/Quick-Reference.aspx. 2013; Accessed: August 19, 2019.

65. Ohto H. [Neonatal alloimmune thrombocytopenia]. Nihon Rinsho. 1997 Sep. 55 (9):2310-4. [Medline].

Shamudheen Rafiyath, MD Medical Oncologist, Hematologist, Arizona Blood and Cancer Specialists

Shamudheen Rafiyath, MD is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ronald A Sacher, MBBCh, FRCPC, DTM&H Professor of Internal Medicine and Pathology, Director, Hoxworth Blood Center, University of Cincinnati Academic Health Center

Ronald A Sacher, MBBCh, FRCPC, DTM&H is a member of the following medical societies: American Association for the Advancement of Science, American Association of Blood Banks, American Clinical and Climatological Association, American Society for Clinical Pathology, American Society of Hematology, College of American Pathologists, International Society of Blood Transfusion, International Society on Thrombosis and Haemostasis, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Srikanth Nagalla, MD, MS, FACP Chief of Benign Hematology, Miami Cancer Institute, Baptist Health South Florida; Clinical Professor of Medicine, Florida International University, Herbert Wertheim College of Medicine

Srikanth Nagalla, MD, MS, FACP is a member of the following medical societies: American Society of Hematology, Association of Specialty Professors

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Alexion; Alnylam; Kedrion; Sanofi; Dova<br/>Serve(d) as a speaker or a member of a speakers bureau for: Dova; Sanofi.

Muhammad A Mir, MD, FACP Assistant Professor of Medicine (Hematology, Blood/Marrow Transplant) Milton S Hershey Medical Center, Pennsylvania State University College of Medicine

Muhammad A Mir, MD, FACP is a member of the following medical societies: American College of Physicians, American Society of Hematology, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology

Disclosure: Nothing to disclose.

Wadie F Bahou, MD Chief, Division of Hematology, Hematology/Oncology Fellowship Director, Professor, Department of Internal Medicine, State University of New York at Stony Brook

Wadie F Bahou, MD is a member of the following medical societies: American Society of Hematology

Disclosure: Nothing to disclose.

Lynnae Millar, MD Professor, Chair, Department of Obstetrics and Gynecology, University of Hawaii, John A Burns School of Medicine

Lynnae Millar, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, American Medical Association, and Society for Maternal-Fetal Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article